Back
abrdn Life Sciences Investors Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
63
HQL
abrdn Life Sciences Investors
Last Price:
$16.86
Seasonality Move:
1.86%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
The current trend is relatively stagnant and HQL is experiencing slight selling pressure.
abrdn Life Sciences Investors Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.82 | Buy |
| 20-day SMA: | 16.96 | Sell |
| 50-day SMA: | 17.01 | Sell |
| 200-day SMA: | 14.32 | Buy |
| 8-day EMA: | 16.87 | Buy |
| 20-day EMA: | 16.93 | Sell |
| 50-day EMA: | 16.75 | Buy |
| 200-day EMA: | 15.16 | Buy |
abrdn Life Sciences Investors Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 49.29 | Sell |
| Chaikin Money Flow: | -24465 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.78 - 17.22) | Sell |
| Bollinger Bands (100): | (14.68 - 17.3) | Buy |
abrdn Life Sciences Investors Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for abrdn Life Sciences Investors Stock
Is abrdn Life Sciences Investors Stock a Buy?
-
abrdn Life Sciences Investors share price is 16.89 while HQL 8-day simple moving average is 16.82, which is a Buy signal.
-
The stock price of HQL is 16.89 while abrdn Life Sciences Investors 20-day SMA is 16.96, which makes it a Sell.
-
abrdn Life Sciences Investors 50-day simple moving average is 17.01 while HQL share price is 16.89, making it a Sell technically.
-
HQL stock price is 16.89 and abrdn Life Sciences Investors 200-day simple moving average is 14.32, creating a Buy signal.
HQL Technical Analysis vs Fundamental Analysis
Buy
63
abrdn Life Sciences Investors (HQL)
is a Buy
Is abrdn Life Sciences Investors a Buy or a Sell?
-
abrdn Life Sciences Investors stock is rated a BuyThe current abrdn Life Sciences Investors [HQL] share price is $16.89. The Score for HQL is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
abrdn Life Sciences Investors Stock Info
Market Cap:
0
Price in USD:
16.89
Share Volume:
122.3K
abrdn Life Sciences Investors 52-Week Range
52-Week High:
17.80
52-Week Low:
10.55
Buy
63
abrdn Life Sciences Investors (HQL)
is a Buy
abrdn Life Sciences Investors Share Price Forecast
-
What is the abrdn Life Sciences Investors stock price today?The abrdn Life Sciences Investors stock price is 16.89 USD today.
-
Will HQL stock go up or go down?abrdn Life Sciences Investors> share price is forecast to RISE/FALL based on technical indicators
-
Is abrdn Life Sciences Investors overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, abrdn Life Sciences Investors is not overvalued.
Is abrdn Life Sciences Investors Stock a Buy?
-
abrdn Life Sciences Investors share price is 16.89 while HQL 8-day exponential moving average is 16.87, which is a Buy signal.
-
The stock price of HQL is 16.89 while abrdn Life Sciences Investors 20-day EMA is 16.93, which makes it a Sell.
-
abrdn Life Sciences Investors 50-day exponential moving average is 16.75 while HQL share price is 16.89, making it a Buy technically.
-
HQL stock price is 16.89 and abrdn Life Sciences Investors 200-day simple moving average is 15.16, creating a Buy signal.
Technical Analysis of abrdn Life Sciences Investors
Should I short abrdn Life Sciences Investors stock?
-
HQL Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting abrdn Life Sciences Investors is a Sell
-
abrdn Life Sciences Investors Relative Strength Index (RSI) is 49.29, which suggest abrdn Life Sciences Investors is oversold
-
The Bollinger Bands (25) for abrdn Life Sciences Investors is (16.78 - 17.22), which suggest abrdn Life Sciences Investors is a Buy
-
The Bollinger Bands (100) for abrdn Life Sciences Investors is (14.68 - 17.3), which suggest abrdn Life Sciences Investors is a Buy
* abrdn Life Sciences Investors stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.